English | Español
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
Patient Daily | Jan 7, 2026

HiArc announces launch of first commercial product at MD&M West 2026
Patient Daily | Jan 7, 2026

Ultragenyx faces setback as key bone drug fails late-stage trial
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026
Patient Daily | Jan 7, 2026

Study finds Milan’s Linate Airport is a significant source of airborne tire-related pollutants
Patient Daily | Jan 7, 2026

FDA approves Vanda's Nereus as first new motion sickness drug in four decades
Patient Daily | Jan 7, 2026

Researchers create first human lung-on-chip model using single-donor stem cells
Patient Daily | Jan 7, 2026

KAIST develops therapy converting tumor-immune cells into direct anticancer agents

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'